Renin Angiotensin system-modifying therapies are associated with improved pulmonary health
Abstract Background Pulmonary diseases are often complicated and have diverse etiologies. One common factor is the lack of therapeutics available for these diseases. The goal of this study was to investigate the impact of Renin-Angiotensin System (RAS)-modifying medications on incidence and time to...
Main Authors: | Maira Soto, Soo I. Bang, Jeff McCombs, Kathleen E. Rodgers |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Clinical Diabetes and Endocrinology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40842-017-0044-1 |
Similar Items
-
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice
by: Maira Soto, et al.
Published: (2020-07-01) -
Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)
by: Matthieu Legrand, et al.
Published: (2019-03-01) -
Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients
by: Theresa I. Shireman, et al.
Published: (2016-11-01) -
Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival
by: Brent Klinkhammer
Published: (2019-08-01) -
Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
by: Tobias Zimmermann, et al.
Published: (2021-04-01)